Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA)

CUSIP: 687604108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
47,863,907
Total 13F shares
52,853,940
Share change
+5,589,327
Total reported value
$1,602,043,688
Put/Call ratio
85%
Price per share
$30.31
Number of holders
143
Value change
+$170,793,609
Number of buys
93
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 687604108?
CUSIP 687604108 identifies ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA) as of Q4 2025

As of 31 Dec 2025, Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,853,940 shares. The largest 10 holders included FMR LLC, VR ADVISER, LLC, Fairmount Funds Management LLC, BlackRock, Inc., VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, Deep Track Capital, LP, RTW INVESTMENTS, LP, Commodore Capital LP, and Paradigm Biocapital Advisors LP. This page lists 143 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.